Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.05 | 1.85 |
NAV | ₹13.22 | ₹32.49 |
Fund Started | 10 Apr 2024 | 09 Oct 2019 |
Fund Size | ₹1714.64 Cr | ₹3052.61 Cr |
Exit Load | Exit load of 0.50%, if redeemed within 30 days. | 0.5% for redemption within 90 Days |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.81% | 5.73% |
3 Year | - | 22.54% |
5 Year | - | 22.77% |
1 Year
3 Year
5 Year
Equity | 98.23% | 81.07% |
Cash | 1.76% | 18.93% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
One97 Communications Ltd. | 5.23% |
Eternal Ltd. | 5.02% |
Astrazeneca Pharma India Ltd. | 3.57% |
Jubilant Ingrevia Ltd. | 3.01% |
BlackBuck Ltd. | 2.98% |
Bajaj Finserv Ltd. | 2.97% |
Varun Beverages Ltd. | 2.55% |
GE Vernova T&D India Ltd. | 2.45% |
Reliance Industries Ltd. | 2.40% |
Amber Enterprises India Ltd. | 2.36% |
Name | Assets |
---|---|
Eternal Ltd. | 4.81% |
Bharti Hexacom Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.56% |
Interglobe Aviation Ltd. | 3.38% |
UNO Minda Ltd. | 3.23% |
Vishal Mega Mart Ltd. | 3.07% |
Maruti Suzuki India Ltd. | 2.96% |
Reliance Industries Ltd. | 2.85% |
GE Vernova T&D India Ltd. | 2.73% |
Krishna Institute of Medical Sciences Ltd | 2.57% |
Name | Prateek Poddar | Arjun Khanna |
Start Date | 07 Jun 2024 | 09 May 2019 |
Name
Start Date
Description | The Scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies following innovation theme. | The scheme seeks to generate capital appreciation from a diversified portfolio of equity, equity related instruments and units of global mutual funds which invests into such companies that utilize new forms of production, technology, distribution or processes which are likely to challenge existing markets or value networks, or displace established market leaders, or bring in novel products and/or business models. |
Launch Date | 10 Apr 2024 | 09 Oct 2019 |
Description
Launch Date